LICENSE AND PATENT ASSIGNMENT AGREEMENTLicense and Patent Assignment Agreement • May 28th, 2020 • Gene Biotherapeutics, Inc. • Biological products, (no disgnostic substances) • New York
This LICENSE AND PATENT ASSIGNMENT AGREEMENT (this “Agreement”) dated as of April 10, 2020 is made by Activation Therapeutics Inc., a Delaware corporation (“Activation”), on its own behalf and on behalf of its Affiliates and Shanxi Taxus Pharmaceuticals Co., Ltd., a company incorporated under the laws of the People’s Republic of China (“Shanxi”), with respect to the following facts:
